Double-blind randomized trials of single-tablet ibuprofen/high-dose famotidine vs. ibuprofen alone for reduction of gastric and duodenal ulcers.
Journal Information
Full Title: Am J Gastroenterol
Abbreviation: Am J Gastroenterol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Gastroenterology
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Guarantor of the article: Loren Laine, MD.: Specific author contributions: Planning and conducting study, analysis/interpretation of data, drafting and revision of the manuscript, approved the final draft submitted: Loren Laine; planning and conducting study, collecting data, interpretation of data, critical review of the manuscript, approved the final draft submitted: Alan J. Kivitz, Alfonso E. Bello, and Michael H. Schiff; analysis/interpretation of data, critical review of the manuscript, approved the final draft submitted: Amy Y. Grahn; analysis/interpretation of data; drafting and critical review of the manuscript, approved the final draft submitted: Ali S. Taha.: Financial support: This study received funding and drugs from Horizon Pharma. The study was designed in collaboration between the sponsors and authors; the sponsor was responsible for collecting data; statistical analyses were performed by the sponsor under the direction of the sponsor and the authors; interpretation of the data and writing of the manuscript were performed by the authors.: Potential competing interests: Loren Laine is a consultant for Horizon Pharma, AstraZeneca, Eisai, and Logical Therapeutics; is on the Data Safety Monitoring Board for Merck, Bayer, and BMS. Alfonso E. Bello is a consultant for Horizon Pharma and Pfizer; is a speaker for Abbott and Amgen. Amy Y. Grahn is an employee of Horizon Pharma. Michael H. Schiff is a consultant for Horizon Pharma. Ali S. Taha is a consultant for Horizon Pharma and Astellas Pharma."
"Financial support : This study received funding and drugs from Horizon Pharma. The study was designed in collaboration between the sponsors and authors; the sponsor was responsible for collecting data; statistical analyses were performed by the sponsor under the direction of the sponsor and the authors; interpretation of the data and writing of the manuscript were performed by the authors."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025